Register entry

Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd.

Data as of · How to read this entry

Registered sites
1
Active NDC listings
4
Live patents
0
Countries
1
Base
China
Authorisation

Registered operations

Active ingredient (API) manufacture1Finished drug manufacture1
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd.333 Jiangnan Road,Hengdian, Dongyang, Zhejiang 322118, China (CHN)Active ingredient (API) manufacture, Finished drug manufacture3003744129420823163
Catalogue

Drug listings by form and route

4

4 active NDC listings: 4 bulk ingredient. By marketing category: BULK INGREDIENT 4.

Dosage formNDCs
powder4
RouteNDCs
Labeller name on the listingNDCs
zhejiang apeloa kangyu pharmaceutical co., ltd.4
Catalogue

Marketed products

4
BrandGeneric nameForm / routeNDC
-Amantadine Hydrochloridepowder66653-003BULK INGREDIENT
-Dextromethorphan Hydrobromidepowder66653-001BULK INGREDIENT
-Pseudoephedrine Hydrochloridepowder66653-004BULK INGREDIENT
-Triclosanpowder66653-005BULK INGREDIENT
Neighbours

Registered in the same town

4
Compare

Comparable companies in China

Enquiry

Common questions

Is Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. FDA approved?
Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. holds 1 FDA-registered establishment in China. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd.'s drugs manufactured?
The FDA register lists Dongyang. Registered operations: active ingredient (API) manufacture, finished drug manufacture.
What drugs does Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. make?
4 products are listed under Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.